↑ Grab this Headline Animator

Information and competitive landscape analysis on more than 120 companies...

Research and Markets (http://www.researchandmarkets.com/reports/c23838) has announced the addition of Analytical Tool - Analysis of Melanoma R&D: The Complete Guide 2005 to their offering



Analysis of "Melanoma Cancer R&D - the Complete Guide" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in melanoma R&D. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future.



This tool provides you with an immense amount of information structured and analyzed to assist you in your work. In-depth analysis is found in a 200+ pages report with almost 100 figures, tables and boxes, which deals with the current therapy strategies employed and opportunities for increased pharmaceutical intervention, in the context of the present competitive landscape for malignant melanoma.



Additionally, included is a CD-ROM searchable database in this tool, which is up to date and reflects the most recent advances in the field of melanoma development. This database will let you go back to source data for in-depth information and lets you present research and development in tables and graphs suited for your own specific purposes.



The package includes:

- Information and competitive landscape analysis on more than 120 companies active in melanoma R&D

- Information on more than 100 industry related melanoma projects

- Progress analysis of more than 60 clinical trials

- Information on 30 preclinical projects

- A multitude of tables and graphs illustrating the most important relations between types of therapy, effects and mechanisms

- Advanced analysis of general and specific trends in the pipeline

- Possibility of performing advanced searches suited to your individual needs



This report will assist you in:

- Tracking cutting edge companies, therapies and new technologies

- Rapid identification of partners & competitors

- Laying down a comprehensive framework for further analysis of the field

- Producing presentations surrounding the development of melanoma therapeutics

- Identifying emerging melanoma products & key areas of pharmaceutical R&D



Example of candidate drugs included:



The complete number of candidate drugs in R&D for melanoma, are more than 100, below are an example of these drugs:



AP 12009, BAY 504798, Bevacizumab, CANVAXIN, CP 4055, DISC-GMCSF, Endostatin, HSPPC 96, Iboctadekin, INO 1001, MEL-VAC, MTI 506, MTI SAM3, MX 128495, Oblimersen, ONCOFLU, OncoVax, OncoVEX GM-CSF, Peginterferon alfa-2b, PI 88, SGN 17/19, TC 101C, TG 1041, TRANSVAX, UVIDEM, VITAXIN MAb and many more.



Companies Mentioned:



Abgenix, Actis Biologics, Ajinomoto, Amgen, Anosys, Antigen Express, Antigenics, Antisense Pharma, Applied Molecular Evolution, Arriani, AVAX Technologies, Avidex, BASF, Bayer, Biokine, bioMerieux, Biomira, Bioniche, BioNumerik, BioWa, BioVex, Bristol-Myers Squibb, Callisto, CancerVax, Celgene, CelSci, Chiron, Chugai, CJ Corp, Clavis, Coley Pharmaceutical, Corixa, CSL, Curacyte, CuraGen, Cytokinetics, Discovery Laboratories, Elan, ELEA, Enichimica, EntreMed, Enzon, GemVax, Genencor, Genentech, Generex Biotechnology, Genetronics, GenQuest, Genta, Genzyme, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Hayashibara, IDM, ImClone Systems, Inotek, Intercell, Intracel, Introgen, Juvaris, KeyCell, Kirin Brewery, KOSAN, KuDOS, Kyowa Hakko, Ligand, Lilly, Lorus Therapeutics, Maxim, Medarex, Medigen Biotechnology, MedImmune, Megapharm, Merck KGaA, Mojave, Myriad, Novartis, Novo Nordisk, Onyx, Orient Europharma, Oxxon, Pfizer, PharmaMar, Pharmexa, Pierre Fabre, Pisa, Point Therapeutics, Progen, Inovio Biomedical Corporation, RegeneRx, Roche, Russian Biotechnologies, Sanofi-aventis, Scancell, Schering-Plough, SciClone, Sclavo, Sequenom, Serono, Sigma-Tau, T-cellic, Therion Biologics, Titan, Transgene, Valentis, VaxGen, Vernalis, Vical, Viragen, ViraNative, Viventia Biotech, Wyeth, ZymoGenetics and more.



For more information visit http://www.researchandmarkets.com/reports/c23838



Laura Wood

Senior Manager

Research and Markets

Fax: +353 1 4100 980

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Desires | Partner Yourself | |

---

4921 readers online...

, Local News